Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

计划入组 32 人 · 首次发布于 2015 年 7 月 10 日

Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

计划入组 3 人 · 首次发布于 2018 年 1 月 29 日

Catheter Over Needle (CON) vs Catheter Through Needle (CTN).

计划入组 70 人 · 首次发布于 2023 年 7 月 27 日

Cpn-10

CCN-007

CIN-209

CHN Nebraska

United States

Can-Fite BioPharma

Israel

ABC CAN PTY LTD

Australia

Samsung Invests $10 Million in C2N Diagnostics to Advance Brain Health Diagnostics

C2N Diagnostics Expands Alzheimer's Blood Test Access Across Asia Through Strategic Partnerships

Splash Clinical and C2N Diagnostics Partner to Revolutionize Alzheimer's Trial Recruitment with Blood-Based Biomarkers